# 185 - Medicine Without Permission | Niklas Anzinger

Page: https://stenobird.com/podcast/free-cities-podcast-5840331/185-medicine-without-permission-niklas-anzinger
Text version: https://stenobird.com/podcast/free-cities-podcast-5840331/185-medicine-without-permission-niklas-anzinger.md
Podcast: [Free Cities Podcast](https://stenobird.com/podcast/free-cities-podcast-5840331)
Published: 2026-06-05T05:00:28+00:00
Episode link: https://fountain.fm/episode/d0sQp6idoayM1GrrVXHx
Audio file: https://feeds.fountain.fm/0Mh804AKI3yaq86kDWTp/items/J5xjeJlrcNfzjnSg9YY1/files/AUDIO---DEFAULT---18102ec4-c7f0-406e-a197-3f2c34f5713e.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/free-cities-podcast-5840331/episodes/185-medicine-without-permission-niklas-anzinger
Duration seconds: 6387

## Resource

Self-Sovereign Medicine: Biotech, Right to Try, and the Cracks in the FDA's Monopoly – Niklas Anzinger is a German entrepreneur who has probably done more than any single person to put Próspera on the longevity biotech map. He is the founder and General Partner of Infinita VC, the first VC fund based in Próspera, Honduras, and the founder and CEO of Infinita City, formerly known as Vitalia, a network of hubs for longevity biotech acceleration. He also hosts the Stranded Technologies podcast, which has featured guests including Naval Ravikant and Balaji Srinivasan. Niklas is a returning guest to the show. Timothy Allen sits down with Niklas in Austin, Texas, a few days after spending a month living alongside him in Próspera, for a wide-ranging conversation that moves from aging as a disease and the FDA's 1962 turning point, through China's rise to 30% of global pharma licensing deals in just ten years, Sid Sijbrandij's AI-assisted cancer fight and the Australian who built a personalised cancer vaccine for his dog using AlphaFold for roughly the cost of a genome sequence, to the Right to Try movement taking shape in Montana and New Hampshire and the regulatory model that could replace the FDA monopoly, and finally to what comes next for Próspera, phase one trials as a commercial beachhead, the Massimo Mazzone profit-first model at Ciudad Morazán, and why the ZEDE framework may be the most underappreciated governance innovation of our time. In this conversation: Why Niklas is spending time in Austin: building a supplementary regulatory pathway to the FDA, modelled on what CLEAR does for TSA airport security Why aging isn't technically a disease and why that distinction is holding longevity biotech back The FDA's 1962 efficacy mandate: when drug costs exploded and pharma l…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/free-cities-podcast-5840331/episodes/185-medicine-without-permission-niklas-anzinger/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/free-cities-podcast-5840331/185-medicine-without-permission-niklas-anzinger.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.